Evidence map›Paper›PMID 35028883›Full record

ArticleInternational journal of hematology2022

Relationship between donor-specific HPA-15 antibodies and poor graft function in HPA-15 mismatched cord blood transplantation.

Masato Yasumi, Takafumi Yokota, Takaya Endo, Shinsuke Kusakabe, Yangsook Koh, Hiroe Sakamoto, Hiroko Inoue, Takao Sudo, Naoki Hosen, Takahiro Karasuno

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Masato YasumiDepartment of Hematology, Rinku General Medical Center, 2-3 Ourai-Kita, Rinku, Izumisano, Osaka, 598-8577, Japan. m-yasumi@rgmc.izumisano.osaka.jp.ORCID http://orcid.org/0000-0003-0320-4685
Takafumi YokotaDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Takaya EndoDepartment of Hematology, Rinku General Medical Center, 2-3 Ourai-Kita, Rinku, Izumisano, Osaka, 598-8577, Japan.
Shinsuke KusakabeDepartment of Hematology, Rinku General Medical Center, 2-3 Ourai-Kita, Rinku, Izumisano, Osaka, 598-8577, Japan.
Yangsook KohJapanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
Hiroe SakamotoJapanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
Hiroko InoueJapanese Red Cross Kinki Block Blood Center, Ibaraki, Japan.
Takao SudoDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Naoki HosenDepartment of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Takahiro KarasunoDepartment of Hematology, Rinku General Medical Center, 2-3 Ourai-Kita, Rinku, Izumisano, Osaka, 598-8577, Japan.
The University of Osaka · JPJapanese Red Cross Society, Japan · JPIzumi City General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor graft function (PGF) is a fatal complication following hematopoietic stem cell transplantation and is influenced by multiple factors, such as donor-specific anti-HLA antibodies, a poor infused CD34

Indexed as

Antigens, Human PlateletCord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationThrombocytopenia, Neonatal AlloimmuneBlood PlateletsHumansInfant, NewbornIsoantibodiesAntigens, Human PlateletIsoantibodiesHPA-15 antibodiesMegakaryopoiesisPoor graft function

Identifiers

PMID35028883
OpenAlexW4206017492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.